Bryce S, Spitz G, Ponsford J Screening for Substance Use Disorders Following Traumatic Brain Injury: Examining the Validity of the AUDIT and the DAST. J Head Trauma Rehabil. 2015 Sep-Oct;30(5):E40-8. doi: 10.1097/HTR.0000000000000091.
Carver CS You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.
Gan C, Gargaro J, Brandys C, Gerber G, Boschen K Family caregivers' support needs after brain injury: a synthesis of perspectives from caregivers, programs, and researchers. NeuroRehabilitation. 2010;27(1):5-18. doi: 10.3233/NRE-2010-0577.
Kolakowsky-Hayner SA, Miner KD, Kreutzer JS Long-term life quality and family needs after traumatic brain injury. J Head Trauma Rehabil. 2001 Aug;16(4):374-85. doi: 10.1097/00001199-200108000-00007.
Kreutzer JS, Gervasio AH, Camplair PS Patient correlates of caregivers' distress and family functioning after traumatic brain injury. Brain Inj. 1994 Apr;8(3):211-30. doi: 10.3109/02699059409150974.
Kreutzer JS, Gervasio AH, Camplair PS Primary caregivers' psychological status and family functioning after traumatic brain injury. Brain Inj. 1994 Apr;8(3):197-210. doi: 10.3109/02699059409150973.
Lefebvre H, Levert MJ The close relatives of people who have had a traumatic brain injury and their special needs. Brain Inj. 2012;26(9):1084-97. doi: 10.3109/02699052.2012.666364. Epub 2012 May 24.
Luker J, Murray C, Lynch E, Bernhardsson S, Shannon M, Bernhardt J Carers' Experiences, Needs, and Preferences During Inpatient Stroke Rehabilitation: A Systematic Review of Qualitative Studies. Arch Phys Med Rehabil. 2017 Sep;98(9):1852-1862.e13. doi: 10.1016/j.apmr.2017.02.024. Epub 2017 Mar 28.
Malouff JM, Thorsteinsson EB, Schutte NS The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis. Clin Psychol Rev. 2007 Jan;27(1):46-57. doi: 10.1016/j.cpr.2005.12.005. Epub 2006 Feb 9.
Murphy MP, Carmine H Long-term health implications of individuals with TBI: a rehabilitation perspective. NeuroRehabilitation. 2012;31(1):85-94. doi: 10.3233/NRE-2012-0777.
Nabors N, Seacat J, Rosenthal M Predictors of caregiver burden following traumatic brain injury. Brain Inj. 2002 Dec;16(12):1039-50. doi: 10.1080/02699050210155285.
Ponsford J, Olver J, Ponsford M, Nelms R Long-term adjustment of families following traumatic brain injury where comprehensive rehabilitation has been provided. Brain Inj. 2003 Jun;17(6):453-68. doi: 10.1080/0269905031000070143.
Powell JM, Fraser R, Brockway JA, Temkin N, Bell KR A Telehealth Approach to Caregiver Self-Management Following Traumatic Brain Injury: A Randomized Controlled Trial. J Head Trauma Rehabil. 2016 May-Jun;31(3):180-90. doi: 10.1097/HTR.0000000000000167.
Rivera PA, Elliott TR, Berry JW, Grant JS Problem-solving training for family caregivers of persons with traumatic brain injuries: a randomized controlled trial. Arch Phys Med Rehabil. 2008 May;89(5):931-41. doi: 10.1016/j.apmr.2007.12.032.
Rotondi AJ, Sinkule J, Balzer K, Harris J, Moldovan R A qualitative needs assessment of persons who have experienced traumatic brain injury and their primary family caregivers. J Head Trauma Rehabil. 2007 Jan-Feb;22(1):14-25. doi: 10.1097/00001199-200701000-00002.
Problem Solving Training for Care Partners of Adults With Traumatic Brain Injury
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.